Usman Tahir (@utahirmd) 's Twitter Profile
Usman Tahir

@utahirmd

Director of #CardioGenetics & Co-Director of #HCM @BidmcCvi | Asst Professor @HarvardMED |#PrecisionMedicine & #Omics

ID: 1269823344561586176

calendar_today08-06-2020 02:47:42

183 Tweet

420 Followers

310 Following

Ahmad Masri (@masriahmadmd) 's Twitter Profile Photo

Myocarditis - more unknown than known. Don't forget to check for a genetic variant, especially DSP, in recurrent disease. When to use immunosuppression? jacc.org/doi/10.1016/j.…

Myocarditis - more unknown than known. 

Don't forget to check for a genetic variant, especially DSP, in recurrent disease. 

When to use immunosuppression? 

jacc.org/doi/10.1016/j.…
Milind Desai MD MBA (@desaimilindy) 's Twitter Profile Photo

Promising early topline results for gene therapy in #hcm. Tremendous thanks to our patients, my research team, co-investigators, and Tenaya Therapeutics for getting us to this point.

BIDMC Research (@bidmc_research) 's Twitter Profile Photo

The latest Circ: Heart Failure includes an editorial by BIDMC Usman Tahir, entitled "Pathways to Precision Medicine in Hypertrophic Cardiomyopathy: Opportunities and Challenges in Plasma Proteomics" Read more: tinyurl.com/mwbmtpe3

Dr. Prashant Rao (@drprao) 's Twitter Profile Photo

Been a busy few months, but excited to share that NIH/NHLBI K23 award was funded! Looking forward to advancing translational research in sports and exercise cardiology 🙌 Very grateful to mentor Robert Gerszten More on the grant👇 bit.ly/42HRfS2 bit.ly/4cg5krF

Been a busy few months, but excited to share that NIH/NHLBI K23 award was funded!

Looking forward to advancing translational research in sports and exercise cardiology 🙌

Very grateful to mentor <a href="/RobGersztenMD/">Robert Gerszten</a>

More on the grant👇
bit.ly/42HRfS2
bit.ly/4cg5krF
Ahmad Masri (@masriahmadmd) 's Twitter Profile Photo

Mavacamten in #nonobstructive #HCM design and baseline characteristics paper is out (ODYSSEY trial) ! Biggest unmet need in HCM is nonobstructive HCM. We look forward to the results. Impressive baseline characteristics with significant burden of disease Sample size caught

Mavacamten in #nonobstructive #HCM design and baseline characteristics paper is out (ODYSSEY trial) ! 

Biggest unmet need in HCM is nonobstructive HCM. We look forward to the results. 

Impressive baseline characteristics with significant burden of disease 

Sample size caught
Ahmad Masri (@masriahmadmd) 's Twitter Profile Photo

Impressive sample size. HCM is a big bucket of things. Not easy to rely solely on a high throughput proteomics platform to differentiate complex phenotypes. We need to do more work in this space. Biggest issue is cost. ahajournals.org/doi/full/10.11… #cardiotwitter

Impressive sample size. HCM is a big bucket of things. Not easy to rely solely on a high throughput proteomics platform to differentiate complex phenotypes. We need to do more work in this space. Biggest issue is cost.  

ahajournals.org/doi/full/10.11…

#cardiotwitter
Dr. Prashant Rao (@drprao) 's Twitter Profile Photo

For those interested in sports cardiology and genetics, below are insights based on last 100 referrals (~60% sports/40% genetics) (Over the past year BIDMC CVI I’ve been seeing athletes with cardiac conditions and caring for patients in the CV genetics program led by Usman Tahir)

Usman Tahir (@utahirmd) 's Twitter Profile Photo

Wonderful to host Alex Bick back in Boston for CV seminar at BIDMC CVI . Great to catch up and hear about exciting advances in CHIP! Fabulous scientist and even better person

Wonderful to host <a href="/AlexBickMDPhD/">Alex Bick</a> back in Boston for CV seminar at <a href="/BidmcCvi/">BIDMC CVI</a> . Great to catch up and hear about exciting advances in CHIP! Fabulous scientist and even better person
Jason H. Wasfy, M.D. (@jasonwasfy) 's Twitter Profile Photo

Leveraging Preexisting Cardiovascular Data to Improve the Detection and Treatment of Hypertension: The NOTIFY-LVH Randomized Clinical Trial | Hypertension | JAMA Cardiology | JAMA Network ⁦Adam Berman, MD MPH⁩ #ACC25 jamanetwork.com/journals/jamac…